Answers are grounded in this paper and cite their sources.
Platelet homeostasis depends on coordinated thrombopoiesis in the bone marrow and adequate platelet survival in the circulation. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation and collapse of antioxidant defenses, may influence both processes. This review summarizes current evidence linking ferroptosis to platelet production and injury. Evidence from studies of hematopoietic stem cells and an in vitro iron-overload model of megakaryopoiesis suggests that ferroptosis-related stress may impair hematopoietic stem/progenitor cell fitness and megakaryocyte differentiation and maturation, thereby reducing platelet production. In parallel, under hemolytic and severe oxidative stress conditions, heme/hemin-driven injury may promote platelet activation, membrane destabilization, and death, contributing to peripheral platelet loss and thrombo-inflammatory complications. However, the ROS accumulation, lipid peroxidation, glutathione depletion, mitochondrial dysfunction, and pharmacological protection reported in circulating platelets do not individually establish ferroptosis, particularly because oxidative injury, inflammatory signaling, and other cell-death pathways may overlap. We further discuss the molecular basis of ferroptosis, focusing on iron handling, lipid peroxidation, and antioxidant defense, with particular emphasis on the extent to which these mechanisms have been demonstrated in megakaryocytes and mature platelets or remain inferred from other cell types. Pharmacological interventions investigated in megakaryocyte- and platelet-related models are also discussed, together with their potential relevance and mechanistic limitations. Overall, available evidence suggests that ferroptosis-related processes may contribute to platelet homeostasis at both the bone marrow and circulatory levels, although the strength of mechanistic evidence differs between these compartments. Integrating cell-specific molecular profiling with functional and mechanistic validation may help resolve the regulatory basis of ferroptosis across hematopoietic stem/progenitor cells, megakaryocytes, and circulating platelets and identify potential therapeutic opportunities for platelet-related disorders.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: